95 related articles for article (PubMed ID: 28272757)
21. Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylation.
Luwor RB; Chin X; McGeachie AB; Robinson PJ; Zhu HJ
Growth Factors; 2012 Aug; 30(4):220-9. PubMed ID: 22574813
[TBL] [Abstract][Full Text] [Related]
22. Intranuclear crosstalk between extracellular regulated kinase1/2 and signal transducer and activator of transcription 3 regulates JEG-3 choriocarcinoma cell invasion and proliferation.
Morales-Prieto DM; Ospina-Prieto S; Chaiwangyen W; Weber M; Hölters S; Schleussner E; Fitzgerald JS; Markert UR
ScientificWorldJournal; 2013; 2013():259845. PubMed ID: 24288470
[TBL] [Abstract][Full Text] [Related]
23. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A.
Terada Y; Kobayashi T; Kuwana H; Tanaka H; Inoshita S; Kuwahara M; Sasaki S
J Am Soc Nephrol; 2005 Aug; 16(8):2296-305. PubMed ID: 15975997
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
25. Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation.
Plaza-Menacho I; van der Sluis T; Hollema H; Gimm O; Buys CH; Magee AI; Isacke CM; Hofstra RM; Eggen BJ
J Biol Chem; 2007 Mar; 282(9):6415-24. PubMed ID: 17209045
[TBL] [Abstract][Full Text] [Related]
26. ERK1/2 contributes negative regulation to STAT3 activity in HSS-transfected HepG2 cells.
Tian ZJ; An W
Cell Res; 2004 Apr; 14(2):141-7. PubMed ID: 15115615
[TBL] [Abstract][Full Text] [Related]
27. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1.
Tian ZJ; Cui W; Li YJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Chen L; An W
Acta Pharmacol Sin; 2004 Sep; 25(9):1157-64. PubMed ID: 15339391
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1.
Li YJ; Cui W; Tian ZJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Xie RQ; Yang XH; Wu YZ; Chen L; An W
Chin Med J (Engl); 2004 Aug; 117(8):1135-42. PubMed ID: 15361284
[TBL] [Abstract][Full Text] [Related]
29. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation.
Ishizawa K; Izawa Y; Ito H; Miki C; Miyata K; Fujita Y; Kanematsu Y; Tsuchiya K; Tamaki T; Nishiyama A; Yoshizumi M
Hypertension; 2005 Oct; 46(4):1046-52. PubMed ID: 16087789
[TBL] [Abstract][Full Text] [Related]
30. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
31. Leukemia inhibitory factor-induced Stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells.
Liu JW; Hsu YC; Kao CY; Su HL; Chiu IM
Stem Cells Dev; 2013 Apr; 22(8):1190-7. PubMed ID: 23205673
[TBL] [Abstract][Full Text] [Related]
32. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
33. Albumin activates ERK via EGF receptor in human renal epithelial cells.
Reich H; Tritchler D; Herzenberg AM; Kassiri Z; Zhou X; Gao W; Scholey JW
J Am Soc Nephrol; 2005 May; 16(5):1266-78. PubMed ID: 15829704
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-7 and epidermal growth factor receptor mediate hypoxia-induced extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase activation and subsequent proliferation in bladder smooth muscle cells.
Sabha N; Aitken K; Lorenzo AJ; Szybowska M; Jairath A; Bägli DJ
In Vitro Cell Dev Biol Anim; 2006; 42(5-6):124-33. PubMed ID: 16848631
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure.
Cheng WH; Lu PJ; Ho WY; Tung CS; Cheng PW; Hsiao M; Tseng CJ
Circ Res; 2010 Mar; 106(4):788-95. PubMed ID: 20056918
[TBL] [Abstract][Full Text] [Related]
36. Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells.
Chen RJ; Ho YS; Guo HR; Wang YJ
Toxicol Sci; 2010 May; 115(1):118-30. PubMed ID: 20106947
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of hispidin against hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblast cells through Akt/GSK-3β and ERK1/2 signaling pathway.
Kim DE; Kim B; Shin HS; Kwon HJ; Park ES
Exp Cell Res; 2014 Oct; 327(2):264-75. PubMed ID: 25128810
[TBL] [Abstract][Full Text] [Related]
38. Pilocapine alters NMDA receptor expression and function in hippocampal neurons: NADPH oxidase and ERK1/2 mechanisms.
Di Maio R; Mastroberardino PG; Hu X; Montero L; Greenamyre JT
Neurobiol Dis; 2011 Jun; 42(3):482-95. PubMed ID: 21397025
[TBL] [Abstract][Full Text] [Related]
39. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells.
Glotin AL; Calipel A; Brossas JY; Faussat AM; Tréton J; Mascarelli F
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4614-23. PubMed ID: 17003459
[TBL] [Abstract][Full Text] [Related]
40. Involvement of ERK1/2 signalling and growth-related molecules' expression in response to heat stress-induced damage in rat jejunum and IEC-6 cells.
Yu J; Yin P; Yin J; Liu F; Zhu X; Cheng G; Guo K; Yin Y; Xu J
Int J Hyperthermia; 2010; 26(6):538-55. PubMed ID: 20707649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
